From: A proteomic analysis of acute leukemia cells treated with 9-hydroxyoctadecadienoic acid
Spot | Accession | Protein name | Gene | M.W. | pI | Score |
---|---|---|---|---|---|---|
mRNA metabolic process | ||||||
13 | Q69YN4 | Protein virilizer homolog↓ | KIAA1429 | 202584.08 | 4.44 | 66.6 |
9 | Q13185 | Chromobox protein homolog 3↓ | CBX3 | 20969.41 | 4.96 | 84.6 |
22 | P61978 | Heterogeneous nuclear ribonucleoprotein K↑ | HNRNPK | 48760.25 | 5.17 | 54.5 |
Protein binding | ||||||
32 | P60709 | Actin, cytoplasmic 1 ↑ | ACTB | 42051.86 | 5.15 | 122 |
23 | P05388 | 60S acidic ribosomal protein P0↑ | RPLP0 | 34388.88 | 5.77 | 170 |
29 | P11171 | Protein 4.1↑ | EPB41 | 81755.32 | 5.54 | 61 |
6 | Q6PK50 | HSP90AB1 protein↓ | HSP90AB1 | 40270.42 | 4.61 | 78.6 |
DNA replication | ||||||
1 | Q01105 | Protein SET↓ | SET | 30974.22 | 3.86 | 98 |
2 | Q01105 | Protein SET↓ | SET | 31310.48 | 3.83 | 202 |
5 | P12004 | Proliferating cell nuclear antigen↓ | PCNA | 29092.42 | 4.31 | 94.1 |
Cytoskeleton | ||||||
21 | P63261 | Actin, cytoplasmic 2 ↑ | ACTG1 | 42107.92 | 5.16 | 321 |
17 | I3L1U9 | Actin, cytoplasmic 2, N-terminally processed↑ | ACTG1 | 23886.98 | 5.11 | 129 |
Apoptosis process | ||||||
26 | P51878 | Caspase-5↑ | CASP5 | 33966.33 | 8.55 | 60.4 |
Negative regulation of myeloid cell differentiation | ||||||
4 | E9PKG1 | Protein arginine N-methyltransferase 1↓ | PRMT1 | 38198.03 | 6.06 | 106 |
Unknown | ||||||
8 | P35527 | Keratin, type I cytoskeletal 9↓ | KRT9 | 62254.9 | 4.89 | 67.1 |
31 | Q15195 | Plasminogen-like protein A↑ | PLGLA | 11135.6 | 6.5 | 63.6 |
28 | Q8IUZ0 | Isoform 3 of Leucine-rich repeat-containing protein↑ | LRRC49 | 74491.59 | 7.15 | 60 |
27 | B4DVQ0 | cDNA FLJ58286, highly similar to Actin, cytoplasmic 2↑ | 37666.76 | 5.45 | 147 | |
20 | B4E335 | cDNA FLJ52842, highly similar to Actin, cytoplasmic 1↑ | 39542.66 | 5.28 | 207 | |
19 | B4DW52 | cDNA FLJ55253, highly similar to Actin, cytoplasmic 1↑ | 38950.3 | 5 | 148 |